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may suppress normal brain maturation in adults [9], mainly of the 
frontal and temporal lobes, which could be accompanied by cognitive 
deterioration. It has also been reported that cocaine-dependent 
subjects have lower gray matter volume than healthy subjects [10]. 
Finally, cognitive disturbance might be the result of acute toxic 
leukoencephalopathy due to cocaine abuse [11,12], most likely caused 
by adulterants [13]. Toxic leukoencephalopathy is characterized by 
progressive damage to myelin and other white matter in the brain 
and is often accompanied by severe neurological symptoms.
Most studies on cognitive changes due to chronic stimulant use 
have a short follow-up time [14]. To our knowledge, permanent 
cognitive disorders due to chronic stimulant use have not yet been 
described in the literature. A major neurocognitive disorder (NCD), 
according to the newest edition of the Diagnostic and Statistical 
Manual of Mental Disorders (DMS-5), is an acquired cognitive 
decline in one or more cognitive domains which interfere significantly 
with a person’s everyday independence [15]. Here we describe a case 
of NCD most likely caused by chronic stimulant use.
Case Report
A 58-year-old woman was admitted to a psychiatric ward 
because of a psychotic episode. Psychiatric history revealed chronic 
daily stimulant use for more than thirty years, specifically cocaine, 
amphetamine and nicotine. She also suffered from a psychotic 
episode at the age of 23 after the death of a child. Medical history did 
not report any somatic comorbidities.
The patient worked in prostitution and had been always able to 
take care of herself and her daughter. Over the past two years, her 
daughter noticed progressive memory problems and behavioral 
changes with self-neglect in the patient. A few months before 
admission her mother started to live more isolated than previously 
and even barricaded her house. She did not trust anybody and she 
seemed to hallucinate. There were also some episodes of aggression 
towards neighbors. Finally, the daughter informed us that her mother 
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Objective: Alert for chronic stimulant use as an etiological factor of 
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Introduction
The prevalence of illicit substance use among older adults is 
rising [1], partly as a consequence of the aging of the baby boom 
generation (born between 1946 and 1964), as within this cohort, 
drug use during youth has been found to be significantly higher 
compared to earlier cohorts [2]. It is likely this will be accompanied 
by greater risks to the older adult, because of age-related changes 
in drug metabolism and neurotransmitter systems mediating drug 
effects in the brain [3]. Furthermore, the prevalence of long-term 
effects of substance use might increase, such as cognitive disorders. 
Long-term substance use, particularly of cocaine, has frequently been 
associated with cognitive deficits [4]. These deficits may be the result 
of several pathophysiological mechanisms. For example, cocaine 
and amphetamine use have been associated with a higher prevalence 
of stroke [5,6] due to compromised cerebral blood flow caused by 
hypertensive surges, vasospasms, enhanced platelet aggregation, 
cerebral vasculitis, accelerated atherosclerosis and cardio-embolism 
[7,8]. Additionally, it has been suggested that chronic cocaine abuse 
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psychotic symptoms were successfully treated with risperidone 4mg 
once daily. After the symptoms subsided, it was possible to reduce 
the antipsychotic treatment gradually. Psychotic symptoms did not 
relapse and risperidone treatment was stopped completely.
Subsequently, however, severe memory impairment and problems 
with planning and organization became apparent. Upon further 
psychiatric assessment, the patient was cooperative, although it was 
hard to make real contact. She was wearing clothes more typically 
worn by younger women. She displayed rapid psychomotor activity 
and was talkative with rapid speech. There were no abnormalities in 
consciousness and the attention of the patient could be drawn easily 
but it was hard to keep her attention on any particular subject. Some 
hypervigilance was observed, as she reacted to every stimulus. The 
patient was disorientated. There were evident disturbances in both 
short- and long-term memory, as well as confabulations. Frequent 
repetitive behavior and perseverations in speech were observed, 
such as continuously asking “When will I go to another city?”. Her 
thought processes were also affected, with flight of ideas seen, and 
mainly relating to smoking and moving to another city. Delusions 
or hallucinations were not observed. Insight and judgment were 
impaired. Mood and affect were normal. Additional examination 
by means of a comprehensive neuropsychological investigation was 
performed. To measure intelligence, the Wechsler Adult Intelligence 
Scale (WAIS) was undertaken. To interpret the scores, we made use 
of the systematic assessment by Kaufman and Lichtenberger [16]. 
Total intelligence level and intelligence on the three sublevels were 
assessed as low. To test her ability and speed to process information, 
a digit symbol substitution test and a symbol search test were 
carried out and the patient scored very low on both. Additionally, 
all scores on several cognitive tests were also low (clock drawing, 
trail making, 15 words memory, fluency, Stroop and Porteus Maze 
tests). On the Mini Mental State Examination [17] she scored 22 out 
of 30. All memory tests were performed chaotically by the patient. 
Consequently, some of the tests could not even be rated. In summary, 
the neuropsychological tests undertaken showed deficits in memory, 
attention, executive functions, information processing speed and 
visuospatial ability.
To investigate the underlying etiology of the established 
cognitive impairment, further assessments were performed. Cerebral 
Magnetic Resonance Imaging (MRI) showed confluent subcortical 
and periventricular white matter lesions (Fazekas 3) and dilated 
ventricles (Figure 1). Carotid ultrasound imaging did not show signs 
of atherosclerosis. Serology for borreliosis, syphilis, hepatitis, HIV 
and paraneoplastic antibodies did not reveal any abnormalities.
What could have caused the psychotic episode and what could be 
the underlying pathophysiological mechanism of the subsequently-
observed cognitive impairment?
Discussion
This patient with a history of chronic daily stimulant use first 
presented with psychotic symptoms. Most likely the psychotic episode 
was induced by substance use, since this is a prevalent precipitator of 
psychosis [18], or by an abrupt cessation of substance use, resulting in 
withdrawal. It seemed likely that patient had been using until recently 
because her daughter found drugs lying around the house. However, 
the negative urinary drugs screening test could support the hypothesis 
of withdrawal as the cause of psychotic symptoms. In any case we 
could state there was vulnerability for psychosis, given the history of 
one psychotic episode. Although less likely, we could also consider 
the psychotic symptoms as neuropsychiatric symptoms emanating 
from a neurocognitive disorder, since cognitive impairment was 
already observed before the psychosis emerged.
After the psychotic symptoms were treated, severe cognitive 
impairment with behavioral problems persisted. Given the results 
of the neuropsychological investigations and combined with her 
decreased independence in daily life, a major neurocognitive disorder 
with behavioral problems was diagnosed.
had said some time ago that she would stop taking drugs as a new 
grandchild had been born. So if she was suffering from withdrawal 
symptoms, it most likely would have been occurring in the weeks 
before admission.
Upon admission, we saw a small White woman (158 cm; 44.5 
kg; Body Masss Index 17.8). Physical and neurological examinations 
did not reveal any abnormalities; however a psychiatric examination 
indicated paranoid delusions and auditory hallucinations. All routine 
haematological and biochemical tests (including complete blood 
count, electrolytes, vitamins, glucose, thyroid, kidney and liver 
function tests) were normal. Urinary drugs screening for cocaine, 
amphetamine and tetrahydrocannabinol were negative.
The patient was admitted to an adult psychiatric ward and 
 
Figure 1: Magnetic Resonance Imaging (MRI) of the cerebrum showed 
strong confluent subcortical and periventricular white matter lesions (Fazekas 
3; MTA 1).
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Based on the clinical presentation and the additional diagnostic 
tests, several etiological subtypes could be excluded, including 
infections and Parkinson’s or Lewy Body’s disease. Due to the early 
onset of cognitive deterioration, with no family history of dementia 
and the absence of hippocampal and cortical atrophy, Alzheimer’s 
disease was deemed unlikely. A vascular or frontotemporal 
neurocognitive disorder was considered, the latter because of the 
observed behavioral disinhibition and perseverative behavior. 
However, neuropsychological investigation showed more global 
cognitive impairment and not exclusively frontotemporal features. 
Additionally, there was no frontal or temporal lobe involvement on 
neuroimaging. Most likely, the cognitive disorder could be attributed 
to the white matter lesions found by the cerebral MRI. Given no 
large vessel disease was found by the ultrasound scan, these lesions 
are most likely the result of microvascular disease due to the effect 
of cocaine and amphetamine on cerebral blood flow [7,8]. Possible 
causes of white matter abnormalities and cognitive impairment in 
substance use are stroke and toxic leukoencephalopathy. However, 
both disorders are most often accompanied by severe neurological 
symptoms. Therefore, we concluded these diagnoses were 
unlikely, since our patient did not have any aberrant neurological 
manifestations. Moreover, the damage from stroke as detected by 
an MRI scan is more localized than the damage seen in our patient. 
Cocaine use has, however, also been associated with the appearance 
of a more confluent pattern of white matter signal hyperintensities 
without neurological symptoms [19,20].
Therefore, we concluded that this major neurocognitive disorder 
with behavioral problems most likely had a vascular etiology as a 
consequence of chronic stimulant use, DSM-5 code 292.82 [15]. 
Giving the rising prevalence of illicit stimulant use among older 
adults [1], it is possible this condition might occur more often in 
the future. More attention should be paid to this upcoming cause 
of neurocognitive disorder. Older adults presenting with cognitive 
impairment should be asked about chronic stimulant use. In case 
of substance use we advise referral to a specialist for neurocognitive 
testing and cerebral imaging.
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